Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Higher serum galactose-deficient immunoglobulin A1 concentration is associated with stronger mesangial cellular inflammatory response and more severe histologic findings in immunoglobulin A nephropathy.

Nguyen C, König K, Tam FWK, Hopfer H, Molyneux K, Binet FI, Kim MJ.

Clin Kidney J. 2018 Aug 3;12(2):232-238. doi: 10.1093/ckj/sfy068. eCollection 2019 Apr.

2.

Galactose-deficient IgA1 in skin and serum from patients with skin-limited and systemic IgA vasculitis.

Neufeld M, Molyneux K, Pappelbaum KI, Mayer-Hain S, von Hodenberg C, Ehrchen J, Barratt J, Suzuki Y, Sunderkötter C.

J Am Acad Dermatol. 2019 Nov;81(5):1078-1085. doi: 10.1016/j.jaad.2019.03.029. Epub 2019 Mar 20.

PMID:
30902725
3.

β1,4-galactosyltransferase 1 is a novel receptor for IgA in human mesangial cells.

Molyneux K, Wimbury D, Pawluczyk I, Muto M, Bhachu J, Mertens PR, Feehally J, Barratt J.

Kidney Int. 2017 Dec;92(6):1458-1468. doi: 10.1016/j.kint.2017.05.002. Epub 2017 Jul 24.

PMID:
28750925
4.

Galactosylation of IgA1 Is Associated with Common Variation in C1GALT1.

Gale DP, Molyneux K, Wimbury D, Higgins P, Levine AP, Caplin B, Ferlin A, Yin P, Nelson CP, Stanescu H, Samani NJ, Kleta R, Yu X, Barratt J.

J Am Soc Nephrol. 2017 Jul;28(7):2158-2166. doi: 10.1681/ASN.2016091043. Epub 2017 Feb 16.

5.

Effect of Immunosuppressive Drugs on the Changes of Serum Galactose-Deficient IgA1 in Patients with IgA Nephropathy.

Kim MJ, Schaub S, Molyneux K, Koller MT, Stampf S, Barratt J.

PLoS One. 2016 Dec 8;11(12):e0166830. doi: 10.1371/journal.pone.0166830. eCollection 2016.

6.

An Ultraconserved Brain-Specific Enhancer Within ADGRL3 (LPHN3) Underpins Attention-Deficit/Hyperactivity Disorder Susceptibility.

Martinez AF, Abe Y, Hong S, Molyneux K, Yarnell D, Löhr H, Driever W, Acosta MT, Arcos-Burgos M, Muenke M.

Biol Psychiatry. 2016 Dec 15;80(12):943-954. doi: 10.1016/j.biopsych.2016.06.026. Epub 2016 Jul 14.

7.

The solution structures of native and patient monomeric human IgA1 reveal asymmetric extended structures: implications for function and IgAN disease.

Hui GK, Wright DW, Vennard OL, Rayner LE, Pang M, Yeo SC, Gor J, Molyneux K, Barratt J, Perkins SJ.

Biochem J. 2015 Oct 15;471(2):167-85. doi: 10.1042/BJ20150612. Epub 2015 Aug 12.

8.

Combined walking exercise and alkali therapy in patients with CKD4-5 regulates intramuscular free amino acid pools and ubiquitin E3 ligase expression.

Watson EL, Kosmadakis GC, Smith AC, Viana JL, Brown JR, Molyneux K, Pawluczyk IZ, Mulheran M, Bishop NC, Shirreffs S, Maughan RJ, Owen PJ, John SG, McIntyre CW, Feehally J, Bevington A.

Eur J Appl Physiol. 2013 Aug;113(8):2111-24. doi: 10.1007/s00421-013-2628-5. Epub 2013 Apr 17.

PMID:
23591985
9.
10.

Disease specific biomarkers of abdominal aortic aneurysms detected by surface enhanced laser desorption ionization time of flight mass spectrometry.

Ehsan S, Ball G, Choke E, Molyneux KM, London NJ, Herbert KE, Barratt J, Sayers RD, Bown MJ.

Eur J Vasc Endovasc Surg. 2012 Jul;44(1):52-4. doi: 10.1016/j.ejvs.2012.04.018. Epub 2012 May 15. Erratum in: Eur J Vasc Endovasc Surg. 2013 Jan;45(1):103.

11.

An update on the pathogenesis and treatment of IgA nephropathy.

Boyd JK, Cheung CK, Molyneux K, Feehally J, Barratt J.

Kidney Int. 2012 May;81(9):833-43. doi: 10.1038/ki.2011.501. Epub 2012 Feb 8. Review.

12.

Abnormal IgD and IgA1 O-glycosylation in hyperimmunoglobulinaemia D and periodic fever syndrome.

de Wolff JF, Dickinson SJ, Smith AC, Molyneux K, Feehally J, Simon A, Barratt J.

Clin Exp Med. 2009 Dec;9(4):291-6. doi: 10.1007/s10238-009-0056-y. Epub 2009 Jun 20.

13.

Is sialylation of IgA the agent provocateur of IgA nephropathy?

Smith A, Molyneux K, Feehally J, Barratt J.

Nephrol Dial Transplant. 2008 Jul;23(7):2176-8. doi: 10.1093/ndt/gfn203. Epub 2008 May 12. No abstract available.

PMID:
18477571
14.

B-cell O-galactosyltransferase activity, and expression of O-glycosylation genes in bone marrow in IgA nephropathy.

Buck KS, Smith AC, Molyneux K, El-Barbary H, Feehally J, Barratt J.

Kidney Int. 2008 May;73(10):1128-36. doi: 10.1038/sj.ki.5002748. Epub 2008 Mar 5.

15.

Immunopathogenesis of IgAN.

Barratt J, Smith AC, Molyneux K, Feehally J.

Semin Immunopathol. 2007 Nov;29(4):427-43. Epub 2007 Sep 13. Review.

PMID:
17851660
16.

O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy.

Smith AC, Molyneux K, Feehally J, Barratt J.

J Am Soc Nephrol. 2006 Dec;17(12):3520-8. Epub 2006 Nov 8.

17.

O-glycosylation of serum IgD in IgA nephropathy.

Smith AC, de Wolff JF, Molyneux K, Feehally J, Barratt J.

J Am Soc Nephrol. 2006 Apr;17(4):1192-9. Epub 2006 Mar 1.

18.

Lymphocyte responses to influenza and tetanus toxoid in vitro following intensive exercise and carbohydrate ingestion on consecutive days.

Bishop NC, Walker GJ, Bowley LA, Evans KF, Molyneux K, Wallace FA, Smith AC.

J Appl Physiol (1985). 2005 Oct;99(4):1327-35. Epub 2005 May 26.

19.

Five polymorphic canine microsatellites.

Molyneux K, Batt RM.

Anim Genet. 1994 Oct;25(5):379. No abstract available.

PMID:
7818193
20.

A single amino acid deletion in the alpha 2(I) chain of type I collagen produces osteogenesis imperfecta type III.

Molyneux K, Starman BJ, Byers PH, Dalgleish R.

Hum Genet. 1993 Feb;90(6):621-8.

PMID:
8444468
21.

Human type III collagen 'variant' is a cDNA cloning artefact.

Molyneux K, Dalgleish R.

Nucleic Acids Res. 1988 Dec 23;16(24):11833. No abstract available.

22.

The effect of citrate in drinks on plaque pH.

Duke SA, Molyneux K, Jackson RJ.

Br Dent J. 1988 Feb 6;164(3):80-2. No abstract available.

PMID:
3422812
23.

Bombesin and calcitonin secretion by pulmonary carcinoma is modulated by cholinergic receptors.

Sorenson GD, Pettengill OS, Cate CC, Ghatei MA, Molyneux KE, Gosselin EJ, Bloom SR.

Life Sci. 1983 Nov 7;33(19):1939-44.

PMID:
6139724

Supplemental Content

Loading ...
Support Center